Abstract
The hippocampus, as well as a variety of other brain regions, is known to receive a diffuse projection of noradrenaline (NA) containing fibres which originates in the brain stem1–4. Although there is considerable evidence for the involvement of this system in a variety of behaviours5–7, the precise cellular actions of NA are poorly understood. Early studies emphasized the direct inhibitory effects of NA8–12; more recent experiments have shown that at several sites, NA, or stimulation of NA-containing afferents, can also facilitate excitatory synaptic responses13–18. This has led to the concept that NA increases the ‘signal-to-noise’ ratio of neurones13, acting as an ‘enabling’ device4 which allows cells to respond more briskly to conventional synaptic excitation. In the olfactory bulb, NA reduces inhibitory postsyn-aptic potentials by a presynaptic action19, which could contribute to enhanced excitatory synaptic responses. However, in other systems, NA has been reported to enhance excitatory responses to iontophoretically applied transmitters, and it was proposed that NA increases the sensitivity of the neurone to these excitatory transmitters13–15. We report here experiments that could explain such direct effects. We have found that NA and cyclic AMP block the Ca2+-activated K+ conductance in hippocampal pyramidal cells and that this blockade occurs at a step subsequent to the entry of Ca2+ into the neurone. As a consequence, the spike frequency adaptation or accommodation which normally occurs with depolarizing stimuli is severely reduced. Thus, NA greatly increases the number of spikes elicited by a depolarizing stimulus.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Pickel, V., Segal, M. & Bloom, F. E. J. comp. Neurol. 155, 15–42 (1974).
Nakamura, S. & Iwama, K. Brain Res. 99, 372–376 (1975).
Loy, R., Koziell, D. A., Lindsey, J. D. & Moore, R. Y. J. comp. Neurol. 189, 699–710 (1980).
Moore, R. Y. & Bloom, F. E. A. Rev. Neurosci. 2, 113–168 (1979).
Mason, S. T. Prog. Neurobiol. 16, 263–303 (1981).
Aston-Jones, G. & Bloom, F. E. Neuroscience 1, 876–886 (1981).
Aston-Jones, G. & Bloom, F. E. Neuroscience 1, 887–900 (1981).
Bloom, F. E. in Psychopharmacology–A 20 Year Progress Report (eds Lipton, M. E., Killam, K. C. & Di Mascio, A.) 131–142 (Raven, New York, 1978).
Hoffer, B. J., Siggins, G. R. & Bloom, F. E. Brain Res. 25, 523–534 (1971).
Segal, M. & Bloom, F. E. Brain Res. 107, 513–525 (1976).
Segal, M. Brain Res. 206, 107–128 (1981).
Langmoen, I. A., Segal, M. & Anderson, P. Brain Res. 208, 349–362 (1981).
Woodward, D. J., Moises, H. C., Waterhouse, B. D., Hoffer, B. J. & Freedman, R. Fedn Proc. 38, 2109–2116 (1979).
Rogawski, M. A. & Aghajanian, G. K. Nature 287, 731–734 (1980).
Waterhouse, B. D., Moises, H. C. & Woodward, D. J. Neuropharmacology 20, 907–920 (1981).
Kayama, Y., Negi, T., Sugitani, M. & Iwama, K. Neuroscience 7, 655–666 (1982).
Mueller, A. L., Hoffer, B. J. & Dunwiddie, T. V. Brain Res. 214, 113–126 (1981).
Moises, H. C., Waterhouse, B. D. & Woodward, D. J. Brain Res. 222, 43–64 (1981).
Jahr, C. E. & Nicoll, R. A. Nature 297, 227–229 (1982).
Nicoll, R. A. & Alger, B. E. J. Neurosci. Meth. 4, 153–156 (1981).
Hotson, J. R. & Prince, D. A. J. Neurophysiol. 43, 409–419 (1980).
Alger, B. E. & Nicoll, R. A. Science 210, 1122–1124 (1980).
Schwartzkroin, P. A. & Stafstrom, C. E. Science 210, 1125–1126 (1980).
Horn, J. P. & McAfee, D. A. J. Physiol., Lond. 301, 191–204 (1980).
Dunlap, K. & Fischbach, G. D. J. Physiol., Lond. 317, 519–535 (1981).
Benardo, L. S. & Prince, D. A. J. Neurosci. 2, 415–423 (1982).
Seamon, K. & Daly, J. W. J. biol. Chem. 256, 9799–9801 (1981).
Klein, M. & Kandel, E. R. Proc. natn. Acad. Sci. U.S.A. 77, 6912–6916 (1980).
Deterre, P., Paupardin-Tritsch, D., Bockaert, J. & Gerschenfeld, H. M. Nature 290, 783–785 (1981).
Adams, W. B. & Levitan, I. B. Proc. natn. Acad. Sci. U.S.A. 79, 3877–3880 (1982).
Kaczmarek, L. R. & Strumwasser, F. Neurosci. Abstr. 7, 932 (1981).
DePeyer, J. E., Cachelin, A. B., Levitan, I. B. & Reuter, H. Proc. natn. Acad. Sci. U.S.A. 79, 4207–4211 (1982).
Livingstone, M. S. & Hubel, D. H. Nature 291, 554–561 (1981).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Madison, D., Nicoll, R. Noradrenaline blocks accommodation of pyramidal cell discharge in the hippocampus. Nature 299, 636–638 (1982). https://doi.org/10.1038/299636a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/299636a0
This article is cited by
-
Ca2+-activated KCa3.1 potassium channels contribute to the slow afterhyperpolarization in L5 neocortical pyramidal neurons
Scientific Reports (2020)
-
Modeling the effect of sleep regulation on a neural mass model
Journal of Computational Neuroscience (2016)
-
The waking brain: an update
Cellular and Molecular Life Sciences (2011)
-
Postsynaptic Reactions in Somatosensory Cortex Neurons Activated by Stimulation of Nociceptors: Modulation upon Stimulation of the Central Grey, Locus Coeruleus, and Substantia Nigra
Neurophysiology (2009)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.